Physician profile
Nicholas C Feipel
NPI 1053758334
$3,481.95
in general payments reported to CMS, 2019-2025
18 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $234 · 2021: $679 · 2022: $832 · 2023: $342 · 2024: $257 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $753.49 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $526.77 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $506.81 | 2019-2021 | |
| Coopervision INC. | $327.28 | 2020-2025 | Misight Contact Lens |
| Mallinckrodt Hospital Products INC. | $229.01 | 2021-2022 | |
| Abbvie INC. | $207.08 | 2022-2023 | |
| Kala Pharmaceuticals, INC. | $192.17 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $153.50 | 2022-2025 | Biotrue One Day, Infuse |
| Shire North American Group INC | $152.02 | 2019 | |
| Oyster Point Pharma, INC. | $134.04 | 2022 | |
| Rxsight INC | $90.19 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $67.42 | 2021-2022 | |
| Allergan, INC. | $40.54 | 2021-2022 | |
| Ocular Therapeutix, INC. | $26.08 | 2021 | |
| Glaukos Corporation | $24.52 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $23.53 | 2021 | |
| Horizon Therapeutics Plc | $15.89 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Feipel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.